Digital Alongside diagnosis: AI’s role in shaping health transformat... Humans are about to go hybrid – in fact, our race is undergoing its own digital transformation.
Partner Content Partner Content Piecing Together the KOL Puzzle Creating a complete picture of your KOLs
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
